HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Distinct Aqueous Humour Cytokine Profiles of Patients with Pachychoroid Neovasculopathy and Neovascular Age-related Macular Degeneration.

Abstract
This study investigated the pathophysiological features of pachychoroid neovasculopathy (PNV) and neovascular age-related macular degeneration (nAMD) by analysing and comparing cytokine profiles in aqueous humour (AH) collected from 18 PNV, 18 nAMD and 11 control patients. Responses to intravitreal injection of aflibercept were also analysed in the PNV and nAMD groups. In the PNV group, vascular endothelial growth factor (VEGF)-A was significantly lower than in the nAMD group (p = 0.03) but was almost identical to that in the control group (p = 0.86). The nAMD group showed positive correlations between interleukin (IL)-6 and IL-8 (r = 0.78, p < 0.001), IL-6 and monocyte chemoattractant protein (MCP)-1 (r = 0.68, p = 0.002) and IL-8 and MCP-1 (r = 0.68, p = 0.002). In the nAMD group, eyes with dry maculae one month after the first aflibercept injection showed significantly lower VEGF-A and placental growth factor (PlGF) at baseline than those with wet maculae (p = 0.02 for both). However, there was no significant difference between dry and wet maculae in the PNV group. The results suggest that angiogenic factors and proinflammatory cytokines may play the distinct roles in the pathogenesis of PNV and nAMD.
AuthorsNobuhiro Terao, Hideki Koizumi, Kentaro Kojima, Tetsuya Yamagishi, Yuji Yamamoto, Kengo Yoshii, Koji Kitazawa, Asako Hiraga, Munetoyo Toda, Shigeru Kinoshita, Chie Sotozono, Junji Hamuro
JournalScientific reports (Sci Rep) Vol. 8 Issue 1 Pg. 10520 (Jul 12 2018) ISSN: 2045-2322 [Electronic] England
PMID30002400 (Publication Type: Comparative Study, Journal Article, Observational Study)
Chemical References
  • Angiogenesis Inhibitors
  • Cytokines
  • Inflammation Mediators
  • Recombinant Fusion Proteins
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Placenta Growth Factor
  • aflibercept
  • Receptors, Vascular Endothelial Growth Factor
Topics
  • Aged
  • Angiogenesis Inhibitors (administration & dosage)
  • Aqueous Humor (drug effects, metabolism)
  • Choroidal Neovascularization (drug therapy, pathology)
  • Cytokines (metabolism)
  • Female
  • Humans
  • Inflammation Mediators (metabolism)
  • Intravitreal Injections
  • Macular Degeneration (drug therapy, pathology)
  • Male
  • Middle Aged
  • Placenta Growth Factor (metabolism)
  • Prospective Studies
  • Receptors, Vascular Endothelial Growth Factor (administration & dosage)
  • Recombinant Fusion Proteins (administration & dosage)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: